Oh, depends on financing? ROFLMAO!!!!!!!!!!!!!!!!!!!!!
Sentiment: Strong Sell
It doesn't matter how phase 3 takes since The interim results will be released this year and the pps will jump. Also, Neuvax will gain early approval just like Kadcyla.
Sentiment: Strong Buy
precisely, the EMILIA phase 3 study of T-DM1 (Kadcyla) is ongoing with an estimated completion date of april 2014.
Pumps won't touch that one! I wonder why?
Well, it's not a secret. Anyone enrolled in the P3 trial will be there for 3 years. The trial will conclude mid-2016.
should be discussed openly...
Wow! Finally a legitimate question of possible concern!!! Congrats to you pacific! Instead of only bashing, why don't we all try to coordinate in getting a sound, objective, accurate, and thorough answer to your question?
dan. You're all pump. Objectivity or a search for truth is the last thing on your agenda. Yu were busted a long time ago.